In particular, TLR7 was shown to be imperative to control COVID-19 disease severity; Van der Made et al. showed that loss-of-function variants of the X-chromosomal TLR7 result in diminished type I and II IFN responses linked to among others to decreased mRNA expression of IRF7 (figure 4). This evidence concerns the gene IRF7 and COVID-19.